GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:26862156
Citation |
Wadosky, KM, Berthiaume, JM, Tang, W, Zungu, M, Portman, MA, Gerdes, AM and Willis, MS (2016) MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo. J. Mol. Endocrinol. 56:273-90 |
---|---|
Abstract |
Thyroid hormone (TH) is recognized for its role in cellular metabolism and growth and participates in homeostasis of the heart. T3 activates pro-survival pathways including Akt and mTOR. Treatment with T3 after myocardial infarction is cardioprotective and promotes elements of physiological hypertrophic response after cardiac injury. Although T3 is known to benefit the heart, very little about its regulation at the molecular level has been described to date. The ubiquitin proteasome system (UPS) regulates nuclear hormone receptors such as estrogen, progesterone, androgen, and glucocorticoid receptors by both degradatory and non-degradatory mechanisms. However, how the UPS regulates T3-mediated activity is not well understood. In this study, we aim to determine the role of the muscle-specific ubiquitin ligase muscle ring finger-1 (MuRF1) in regulating T3-induced cardiomyocyte growth. An increase in MuRF1 expression inhibits T3-induced physiological cardiac hypertrophy, whereas a decrease in MuRF1 expression enhances T3's activity both in vitro and in cardiomyocytes in vivo MuRF1 interacts directly with TRα to inhibit its activity by posttranslational ubiquitination in a non-canonical manner. We then demonstrated that a nuclear localization apparatus that regulates/inhibits nuclear receptors by sequestering them within a subcompartment of the nucleus was necessary for MuRF1 to inhibit T3 activity. This work implicates a novel mechanism that enhances the beneficial T3 activity specifically within the heart, thereby offering a potential target to enhance cardiac T3 activity in an organ-specific manner. |
Links |
PubMed PMC5453669 Online version:10.1530/JME-15-0283 |
Keywords |
Animals; Biopsy; Cardiomegaly/diagnostic imaging; Cardiomegaly/etiology; Cardiomegaly/metabolism; Cardiomegaly/pathology; Cell Line; Echocardiography; Mice; Mice, Knockout; Muscle Proteins/metabolism; Mutation; Myocytes, Cardiac/metabolism; Protein Binding; Protein Interaction Domains and Motifs; Rats; Thyroid Hormone Receptors alpha/chemistry; Thyroid Hormone Receptors alpha/genetics; Thyroid Hormone Receptors alpha/metabolism; Triiodothyronine/adverse effects; Tripartite Motif Proteins/metabolism; Ubiquitin-Protein Ligases/metabolism; Ubiquitination |
Significance
Annotations
Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
---|---|---|---|---|---|---|---|---|
GO:0006513: protein monoubiquitination |
ECO:0000314: |
P |
The organism is Mus Musculus and the protein is referred to as MuRF1 ( muscle-specific ubiquitin ligase muscle ring finger-1 ) in the article but is actually called TRI63. Figure 5C showss that MuRF1 is able mono- ubiquitinate TRalpha (thyroid receptor protein). |
complete | ||||
Notes
See also
References
See Help:References for how to manage references in GONUTS.